J. Caillon
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 60
-
- Antibiotic Use and Resistance 21
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 30
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 50
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 49
-
- Infective Endocarditis Diagnosis and Management 25
- Pneumonia and Respiratory Infections 24
-
- Orthopedic Infections and Treatments 20
- Co-authors
- Cédric JacquelineG. PotelÉric BatardChristèle Gras‐Le GuenV. Le MabecqueDenis BugnonH DrugeonJean‐Christophe Rozé
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)Journal of Antimicrobial Chemotherapy (18 papers)European Journal of Clinical Microbiology & Infectious Diseases (12 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
J. Caillon
183 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 134
- Molecular Medicine 759
- Applied Microbiology and Biotechnology 241
- Clinical Biochemistry 451
- Infectious Diseases 958
- Pharmacology 689
Countries citing papers authored by J. Caillon
This map shows the geographic impact of J. Caillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Caillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Caillon more than expected).
Fields of papers citing papers by J. Caillon
This network shows the impact of papers produced by J. Caillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Caillon. The network helps show where J. Caillon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Caillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2020 | 3 | |
| 4 | 2019 | 18 | |
| 5 | 2018 | 5 | |
| 6 | 2017 | 3 | |
| 7 | 2016 | 19 | |
| 8 | 2015 | 74 | |
| 9 | 2015 | 2 | |
| 10 | 2014 | 11 | |
| 11 | 2014 | 27 | |
| 12 | 2013 | 2 | |
| 13 | 2013 | 41 | |
| 14 | 2011 | 2 | |
| 15 | 2010 | 53 | |
| 16 | 2009 | 5 | |
| 17 | 2005 | 11 | |
| 18 | 2000 | 121 | |
| 19 | Septicémie à Vibrio cholerae non 01. | 1989 | 2 |
| 20 | [Experimental Enterobacter cloacae endocarditis treated with gentamicin. Predictive value of the in vitro bactericidal rate]. | 1988 | 1 |
About J. Caillon
J. Caillon is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 192 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (60 papers), Antimicrobial Resistance in Staphylococcus (50 papers), Antibiotics Pharmacokinetics and Efficacy (49 papers), Bacterial Identification and Susceptibility Testing (30 papers), Infective Endocarditis Diagnosis and Management (25 papers), Pneumonia and Respiratory Infections (24 papers), Antibiotic Use and Resistance (21 papers) and Orthopedic Infections and Treatments (20 papers). The work is most often cited by research in Molecular Medicine (759 citations), Applied Microbiology and Biotechnology (241 citations) and Clinical Biochemistry (451 citations). J. Caillon has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Cédric Jacqueline, G. Potel, Éric Batard, Christèle Gras‐Le Guen, V. Le Mabecque, Denis Bugnon, H Drugeon, Jean‐Christophe Rozé, David Boutoille and A.-F. Miegeville. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, International Journal of Antimicrobial Agents and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.